181 related articles for article (PubMed ID: 8106155)
1. An overview of experience with TAXOL (paclitaxel) in the U.S.A.
Donehower RC; Rowinsky EK
Cancer Treat Rev; 1993; 19 Suppl C():63-78. PubMed ID: 8106155
[TBL] [Abstract][Full Text] [Related]
2. Overview of paclitaxel (TAXOL).
Martin V
Semin Oncol Nurs; 1993 Nov; 9(4 Suppl 2):2-5. PubMed ID: 7904376
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview.
Hájek R; Vorlicek J; Slavik M
Neoplasma; 1996; 43(3):141-54. PubMed ID: 8841500
[TBL] [Abstract][Full Text] [Related]
4. Update on the antitumor activity of paclitaxel in clinical trials.
Rowinsky EK
Ann Pharmacother; 1994 May; 28(5 Suppl):S18-22. PubMed ID: 7915154
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel: current developmental approaches of the National Cancer Institute.
Arbuck SG
Semin Oncol; 1995 Dec; 22(6 Suppl 15):55-63. PubMed ID: 8643972
[TBL] [Abstract][Full Text] [Related]
6. Use of paclitaxel (Taxol) in squamous cell carcinoma of the head and neck.
Forastiere AA
Semin Oncol; 1993 Aug; 20(4 Suppl 3):56-60. PubMed ID: 8102018
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel (Taxol) in breast cancer.
Arbuck SG; Dorr A; Friedman MA
Hematol Oncol Clin North Am; 1994 Feb; 8(1):121-40. PubMed ID: 7908664
[TBL] [Abstract][Full Text] [Related]
8. Taxol: initial Israeli experience with a novel anticancer agent.
Sulkes A; Beller U; Peretz T; Shacter J; Hornreich G; McDaniel C; Winograd B
Isr J Med Sci; 1994 Jan; 30(1):70-8. PubMed ID: 7908013
[TBL] [Abstract][Full Text] [Related]
9. Taxol: the first of the taxanes, an important new class of antitumor agents.
Rowinsky EK; Onetto N; Canetta RM; Arbuck SG
Semin Oncol; 1992 Dec; 19(6):646-62. PubMed ID: 1361079
[TBL] [Abstract][Full Text] [Related]
10. Taxol: a promising new drug of the '90s.
Rogers BB
Oncol Nurs Forum; 1993; 20(10):1483-9. PubMed ID: 7904060
[TBL] [Abstract][Full Text] [Related]
11. Taxol reactions.
Price KS; Castells MC
Allergy Asthma Proc; 2002; 23(3):205-8. PubMed ID: 12125509
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel in cancer therapy.
Mekhail TM; Markman M
Expert Opin Pharmacother; 2002 Jun; 3(6):755-66. PubMed ID: 12036415
[TBL] [Abstract][Full Text] [Related]
13. [Taxol--a new cytostatic drug for therapy of ovarian and breast cancer].
Meden H; Rath W; Kuhn W
Geburtshilfe Frauenheilkd; 1994 Apr; 54(4):187-93. PubMed ID: 7912212
[TBL] [Abstract][Full Text] [Related]
14. Overview of paclitaxel (Taxol) in advanced lung cancer.
Ettinger DS
Semin Oncol; 1993 Aug; 20(4 Suppl 3):46-9. PubMed ID: 8102017
[TBL] [Abstract][Full Text] [Related]
15. [Evidenced-based medicine and future direction of Taxol].
Hatae M; Nakamura T; Ohnishi Y
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1279-87. PubMed ID: 10945027
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel: a new antineoplastic agent for refractory ovarian cancer.
Gregory RE; DeLisa AF
Clin Pharm; 1993 Jun; 12(6):401-15. PubMed ID: 7691462
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel (Taxol) and docetaxel (Taxotere): active chemotherapeutic agents in lung cancer.
Francis PA; Kris MG; Rigas JR; Grant SC; Miller VA
Lung Cancer; 1995 Apr; 12 Suppl 1():S163-72. PubMed ID: 7551925
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological action of paclitaxel].
Potemski P; Płuzańska A
Pol Merkur Lekarski; 1999 Jan; 6(31):27-9. PubMed ID: 10344150
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel (taxol).
Kohler DR; Goldspiel BR
Pharmacotherapy; 1994; 14(1):3-34. PubMed ID: 7909150
[TBL] [Abstract][Full Text] [Related]
20. Clinical development of Taxol.
Arbuck SG; Christian MC; Fisherman JS; Cazenave LA; Sarosy G; Suffness M; Adams J; Canetta R; Cole KE; Friedman MA
J Natl Cancer Inst Monogr; 1993; (15):11-24. PubMed ID: 7912517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
